Trial document

drksid header


Trial Description

start of 1:1-Block title


Lung Ultrasound in Covid-19 Pneumonia

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym


end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial


end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language


end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

Prospective evaluation of the agreement between Lung-Ultrasound according to the Basic Lung Ultrasound in Emergency (BLUE)-protocol and computed tomography of the lungs in diagnosis of viral pneumonia.

end of 1:1-Block scientific synopsis
start of 1:1-Block forwarded Data

Do you plan to share individual participant data with other researchers?


end of 1:1-Block forwarded Data
start of 1:1-Block forwarded Data Content

Description IPD sharing plan:


end of 1:1-Block forwarded Data Content
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00021585
  •   2020/04/29
  •   [---]*
  •   yes
  •   Approved
  •   Eth08-20, Ethik-Kommission der Ärztekammer Berlin
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  • [---]*
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   J12.8 -  Other viral pneumonia
  •   U07.1 -  Emergency use of U07.1
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   Lung Ultrasound
  •   CT thorax
end of 1:N-Block interventions
start of 1:1-Block design


  •   Interventional
  •   [---]*
  •   Other
  •   Blinded
  •   assessor
  •   Other
  •   Diagnostic
  •   Other
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

Cohen`s kappa regarding the binary outcome pulmonary opacities/infiltrations yes/no by both Methods.

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

sensitivity and specificity of lung ultrasound for pulmonary infiltrates

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • Medical Center 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment


  •   Actual
  •   2020/04/24
  •   220
  •   Monocenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   18   Years
  •   no maximum age
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

acute respiratory symptoms (cough, sore throat) and one of three: dyspnea, age > 60, relevant comorbidity (Diabetes, cardiovascular or chronic pulmonary) and Temperature > 37.3°C or lymphopenia < 1.1 G/L

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

not able to consent, lack of informed consent, unstable Patient, age < 18yrs

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses


end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

end of 1:n-Block material support
start of 1:1-Block state


  •   Recruiting complete, follow-up complete
  •   [---]*
  •   [---]*
  •   2021/04/21
  •   222
  •   222
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.